Search Results

We have developed an array of fluorescent biosensors to map kinase activity in living cells and are exploring

medicinal chemist in Italy, followed by a Ph.D. in computational medicinal chemistry, during which she developed

(MFI): a reliable, self-sustaining computational chemistry service provider, developing its own software

Alice Ting developing programmable receptors for molecular sensing and controlling cellular behaviour

Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors

She developed expertise over the past two decades studying structure/function relationships of GPCRs

information on dysregulated signaling circuitries and individual genomic and molecular alterations to develop

He has developed novel tools and methodologies to study fungal GPCRs which allowed the determination

co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development

Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class

She is an internationally recognized biophysicist for her contributions in developing constrained molecular

Pivoting: Redefining the Pain Research Playbook Looking ahead, Serafini’s vision is bold: build a lab that develops He aspires to become a physician-scientist, with a focus on translational in vitro and in vivo model development Other academic interests of his include studying pharmaceutical finance & healthcare administration and developing

deciphering of cellular and organ functions, which require individual adhesion GPCRs, and extends to the development

Professor Pfleger has developed extensive expertise in profiling receptor binding and function at the

Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular

Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular

Pydi's laboratory is to develop GPCR-based drugs for the treatment of obesity and Type 2 Diabetes (T2D

The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic development

His group recently developed an online resource of biased ligands and pathway effects to advance the

He has developed innovative methods for in-cellulo measurement of protein-protein interactions, receptor

I am continuing with the development of advanced screening approaches in the Madan Babu lab to progress

To study GPCR signalling, they develop and use innovative optical methods based on FRET and single-molecule

Lefkowitz , where his research focused on biased agonism, with the development of approaches to quantify

to elucidate the role of steroidogenesis in regulating sexual determination and adrenal and gonadal development

She developed expertise over the past two decades studying structure/function relationships of GPCRs

Lefkowitz, where his research focused on biased agonism, with the development of approaches to quantify

these benefits are designed to enhance your research experience and keep you informed about the latest developments benefit Premium Yearly for Teams $212.49 per year • 15% discount Minimum 5 seats Get Your Team Discount Developing We have a 90% discount for people who live and work in developing countries and a 15% discount for team

GPCR Drug Discovery Learn modern approaches to GPCR-targeted drug discovery and development. Biased Signaling Understanding and exploiting biased agonism in GPCR drug development. We have a 90% discount for people who live and work in developing countries and a 15% discount for team

Children with GRIN disorder experience developmental delays, intellectual impairment, visual impairments Our laboratory is working to help patients by developing genetically-modified mice that have disease-causing

In 2018, Bianca was appointed Vice-Chancellor’s Fellow at Queen’s University Belfast to develop her research